Bionano Genomics, Inc. (BNGO) Q1 2026 Earnings Call

Replay

Replay transcript excerpt

Good day, and welcome to the BioNano first quarter 2026 earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb Campbell from Gilmartin Group. Please go ahead. Thank you, Liz, and good afternoon, everyone. Welcome to the BioNano first quarter 2026 financial results conference call. On the call today is Dr. Al Luterer, Chairman and Interim CEO of BioNano, and Mark Adamchak, Bionano's Vice President of Accounting and Principal Accounting Officer. After market closed today, Bionano issued a press release announcing its financial results for the first quarter of 2026. A copy of the release can be found on the investor relations page of the company's website. Certain statements made during this conference call may be forward-looking statements. Actual results may differ materially from such statements due to several factors and risk. some of which are identified in BioNano's press release and BioNano's reports filed with the SEC. These forward-looking statements are based on information available to BioNano today, May 13, 2026, and the company assumes no obligation to update statements as circumstances change. During our call, we may refer to certain adjusted financial measures, which we believe provide useful information for investors. Reconciliations of these measures to GAAP can be found in our press release and slide deck. An audio recording and webcast replay for today's conference call will also be available online on the investor relations page of the company's website. With that, I will turn the call over to Al. Thank you, Webb, and good afternoon, everyone. I'm pleased to be here with you all today. Before I share an update on our first quarter, I want to address the recent leadership transiti...